Jeffrey Williams has been named CEO of HandyLab, which develops clinical diagnostic products. He comes to HandyLab from Genomic Solutions, where he was a co-founder and CEO until its acquisition by Harvard Biosciences in 2002, and where he subsequently headed up the Genomic Solutions unit.
Prior to co-founding Genomic Solutions, Williams served as chief operating officer of International Remote Imaging Systems, which specialized in digital imaging for the clinical diagnostic and research markets. He also held the position of vice president and global business manager for clinical diagnostics at Boehringer Mannheim, now part of Hoffman LaRoche, and held positions at the Organon Pharmaceutical division of Akzo Nobel.
Myriad Genetics has appointed Dennis Langer to its board of directors. Langer, who will begin his position on May 1, is president of Dr. Reddy’s Laboratories. Before coming to Dr. Reddy’s, he was senior vice president for R&D project and portfolio management at GlaxoSmithKline.
Langer has a JD from Harvard Law School, an MD from Georgetown University School of Medicine, and a BA in biology from Columbia University. He currently serves on the board of Transkaryotic Therapies, and on the boards of visitors at Columbia University, and Georgetown University School of Medicine.